Effect of Metformin and Rosiglitazone Over no Diabetic With Metabolic Syndrome Patients.

Condition:   Insulin Resistance Interventions:   Drug: Metformin group;   Drug: Rosiglitazone group;   Drug: Placebo oral tablet Sponsors:   J JESUS VENEGAS, MD;   Instituto Mexicano del Seguro Social;   National Council of Science and Technology, Mexico Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials